Patel M V, Chen K W, Schröder R. "一种舒尼替尼杂质77的合成方法" [P]. US Patent, US 9035076 B2, 2025-08-12.
发明人李文辉,赵玉洁,郑宇鹏. "Method for the Synthesis of Sunitinib Impurity 77" [P]. 中国发明专利, 专利号 CN 109055929 A, 授权公告日 2016-05-12.
Davis P L, Mueller T, Williams B T. "A Process for Preparing High-Purity Sunitinib Impurity 77" [P]. US Patent, US 10785524 B2, 2019-03-05.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 舒尼替尼杂质77 in Pharmaceutical Formulations". Sci. Total Environ., 2015, 931, 7422-7434.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 舒尼替尼杂质77 as an Impurity". Chromatographia, 2017, 1071, (3), 2648-2656.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Sunitinib Impurity 77 Using HRMS and NMR". J. Nat. Prod., 2018, 1110, (3), 5566-5585.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 舒尼替尼杂质77 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2016, 2266, (1), 3610-3620.